UPDATED Mar 15, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
IQST | US$0.24 | -3.9% | 58.1% | US$45.6m | n/a | PB5x | n/a | n/a | ||
SPOK | US$17.07 | -3.0% | 78.4% | US$338.9m | US$18.00 | PE21.9x | E10.3% | 7.3% | ||
IDT | US$37.99 | 1.6% | 12.0% | US$964.5m | n/a | PE26.1x | n/a | 0.5% | ||
IGLD.F | US$1.97 | 0% | n/a | US$4.4m | n/a | PB2.7x | n/a | n/a | ||
CIBY | US$1,825.00 | 0.3% | 2.8% | US$23.1m | n/a | PE80.6x | n/a | n/a | ||
SURG | US$4.63 | -26.6% | 14.2% | US$88.2m | US$11.50 | PE4.3x | n/a | n/a | ||
FULO | US$0.20 | 0% | -47.3% | US$3.9m | n/a | PE8.1x | n/a | 6.6% | ||
MACT | US$7.00 | -6.7% | n/a | US$18.0m | n/a | PE4.6x | n/a | n/a | ||
NXPL | US$1.38 | -7.4% | -14.3% | US$25.8m | n/a | PS1.1x | n/a | n/a | ||
UCL | US$1.42 | -6.0% | -60.7% | US$52.5m | US$9.50 | PE18.7x | S23.9% | n/a | ||
ATEX | US$34.59 | -3.9% | 15.6% | US$640.6m | US$69.50 | PE40.5x | E-87.7% | n/a | ||
OOMA | US$8.65 | -7.4% | -31.2% | US$223.2m | US$15.60 | PB2.9x | E45.5% | n/a | ||
ASTS | US$3.14 | 4.3% | -48.8% | US$808.0m | US$13.50 | PB3.4x | E56.3% | n/a | ||
SHEN | US$17.60 | -3.9% | -7.5% | US$887.9m | US$25.00 | PE110.5x | E-132.7% | 0.5% | ||
CRGE.Q | US$0.0088 | -20.0% | -99.3% | US$1.5m | n/a | PB0.08x | n/a | n/a | ||
VPLM | US$0.016 | -0.3% | -67.5% | US$48.3m | n/a | PB23x | n/a | n/a | ||
FNGR | US$2.14 | -3.6% | 62.1% | US$117.7m | n/a | PS2.8x | n/a | n/a | ||
LICT | US$16,100.00 | -0.6% | -14.8% | US$273.2m | n/a | PE27x | n/a | n/a |